New Delhi, April 7 Biocon Ltd announced on Tuesday the commercial launch of biosimilars Bosaya and Aukelso, indicated for different serious bone conditions, in the US.Bosaya (a biosimilar to Prolia) and Aukelso (a biosimilar to Xgeva) are now available by prescription nationwide through...
New Delhi, March 24 Chemicals and Fertilizers Minister J P Nadda highlighted on Tuesday that there are 18,646 Jan Aushadhi Kendras across the country that provide affordable generic medicines to people.Responding to supplementary queries during Question Hour in Rajya Sabha, the minister said...
essential drugs
generic medicines
government hospitals
health services
healthcare accessibility
india
jan aushadhi kendras
medicines
ministry of health
national list of essential medicines
out-of-pocket expenditure (oope)
pharmaceutical distribution
pharmaceuticalproducts
pradhan mantri bharatiya janaushadhi pariyojana
public health facilities
supply chain management
New Delhi, March 3 NATCO Pharma announced on Tuesday the launch of generic Pomalidomide capsules in the US market, indicated for the treatment of adult patients with blood and bone marrow cancer, in partnership with Breckenridge Pharmaceutical, Inc.Pomalidomide capsule is a generic version of...
blood cancer
bone marrow cancer
breckenridge pharmaceutical
cancer treatment
drug development
fda approval
generic pharmaceuticals
hiv
kaposi sarcoma
multiple myeloma
natco pharma
pharmaceuticalproducts
pomalidomide
specialty pharmacies
us market
New Delhi, February 27 Glenmark Pharmaceuticals announced on Friday that its US-based unit is preparing to introduce a generic sodium phosphate injection in the American market.The Mumbai-based pharmaceutical company stated that its product is therapeutically equivalent to Hosira Inc.'s...
bse stock exchange
drug sales
generic drug
glenmark pharmaceuticals
india
injection
iqvia sales data
pharmaceutical distribution
pharmaceutical industry
pharmaceutical market
pharmaceuticalproducts
regulatory filing
sodium phosphate injection
united states
us market